Last reviewed · How we verify
NCT05635539
Weight Loss in Patients With COVID-19 and Influenza in Comorbidity With NCDs: a Pilot Prospective Clinical Trial
NA trial testing "Analimentary detoxication" (ANADETO) weight loss based on very-low-calorie-diet in Clinical Trial in 62 participants. Completed in 31 July 2022.
30 April 2022
Quick facts
| Lead sponsor | University Medical Center, Kazakhstan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 62 |
| Start date | 1 August 2020 |
| Primary completion | 30 April 2022 |
| Estimated completion | 31 July 2022 |
| Sites | 1 location across Kazakhstan |
Drugs / interventions tested
- "Analimentary detoxication" (ANADETO) weight loss based on very-low-calorie-diet
Conditions studied
- Clinical Trial — all drugs for Clinical Trial →
Sponsor
University Medical Center, Kazakhstan
Who can join
Adults 25 to 80, any sex, with Clinical Trial. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study was to evaluate the effects of the fast weight loss on clinic and laboratory inflammation profile, metabolic profile, reactive oxygen species (ROS) and body composition in patients with COVID and Influenza in comorbidity with NCDs. Primary endpoints: Clinic/infectious/inflammation tests for COVID and Influenza; weight loss during 14 days. Secondary endpoints: fasting blood glucose, HbA1c, blood insulin; systolic/diastolic BP; blood lipids; ALT, AST, chest CT-scan.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Weight loss treatment for COVID-19 in patients with NCDs: a pilot prospective clinical trial.
Oshakbayev K, Durmanova A, Zhankalova Z, Idrisov A, et al · · 2024 · cited 2× · PMID 38744929 · DOI 10.1038/s41598-024-61703-1 -
Weight loss treatment of COVID-19 in patients with NCDs: a pilot prospective clinical trial
Oshakbayev K, Durmanova A, Zhankalova Z, Idrisov A, et al · · 2023 · DOI 10.21203/rs.3.rs-2754577/v1 -
Weight loss in patients with COVID-19 and Influenza in comorbidity with NCDs: a pilot prospective clinical trial
Oshakbayev K, Durmanova A, Idrisov A, Zhankalova Z, et al · · 2022 · DOI 10.1101/2022.12.04.22283077
Verify or expand the search:
- PubMed search for NCT05635539
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Clinical Trial
Currently open trials in the same condition.
- NCT06562387 — tDCS as Adjunctive Therapy to Cognitive Stimulation in Medical Students With Depression · NA · active not recruiting
- NCT04691700 — GOREISAN for Heart Failure (GOREISAN-HF) Trial · Phase 4 · active not recruiting
Other University Medical Center, Kazakhstan trials
Trials by the same sponsor.
- NCT06410352 — Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome · Phase 4 · recruiting
- NCT04762849 — A Banded One Anastomosis Gastric Bypass With Use Shape-memory Ring Versus Non-banded One Anastomosis Gastric Bypass · NA · withdrawn
- NCT05654974 — Sexual Habits Affect Penis Size in Adulthood · completed
- NCT03667469 — Study of the Life Expectancy of Patients With Metabolic Syndrome After Weight Loss: · NA · completed
- NCT03454867 — Hemofiltration in Acute Ischemic Stroke · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05635539 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Center, Kazakhstan
- Last refreshed: 29 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05635539.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing